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ABSTRACT Human African trypanosomiasis is caused by two subspecies of Trypanosoma brucei. Trypanosoma brucei rhod-
esiense is found in East Africa and frequently causes acute disease, while Trypanosoma brucei gambiense is found in West Africa
and is associated with chronic disease. Samples taken from a single focus of a Ugandan outbreak of T. b. rhodesiense in the 1980s
were associated with either chronic or acute disease. We sequenced the whole genomes of two of these isolates, which showed
that they are genetically distinct from each other. Analysis of single nucleotide polymorphism markers in a panel of 31 Ugandan
isolates plus 32 controls revealed a mixture of East African and West African haplotypes, and some of these haplotypes were as-
sociated with the different virulence phenotypes. It has been shown recently that T. b. brucei and T. b. rhodesiense populations
undergo genetic exchange in natural populations. Our analysis showed that these strains from the Ugandan epidemic were inter-
mediate between the reference genome sequences of T. b. gambiense and T. b. brucei and contained haplotypes that were present
in both subspecies. This suggests that the human-infective subspecies of T. brucei are not genetically isolated, and our data are
consistent with genomic introgression between East African and West African T. b. brucei subspecies. This has implications for
the control of the parasite, the spread of drug resistance, and understanding the variation in virulence and the emergence of hu-
man infectivity.
IMPORTANCE We present a genetic study of the acute form of “sleeping sickness” caused by the protozoan parasite Trypanosoma
brucei rhodesiense from a single outbreak in Uganda. This represents an advance in our understanding of the relationship be-
tween the T. b. rhodesiense and Trypanosoma brucei gambiense subspecies that have previously been considered geographically
distinct. Our data suggest that introgression of West African-derived T. brucei haplotypes may be associated with differences in
disease presentation in the East African disease. These findings are not only of scientific interest but also important for parasite
control, as they suggest that the human-infective T. brucei subspecies are not genetically isolated.
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Human African trypanosomiasis (HAT) is a neglected tropicaldisease caused by two subspecies of the protozoan parasite
Trypanosoma brucei. Together, these species cause around 10,000
notified cases per annum, although the actual figure is likely to be
much greater due to the difficulties associated with monitoring
the disease (1). The distribution of the disease is limited only by
the presence of its vector, the tsetse fly (Glossina subsp.), and by
this measure, the disease is endemic in 36 countries in sub-
Saharan Africa (2). Two other species of Trypanosoma, T. congo-
lense andT. vivax, cause significant disease in livestock, costing the
economies of the affected countries an estimated $1 billion every
year (3).
The distinction between the subspecies of Trypanosoma brucei
is coming under increased scrutiny. Originally proposed byHoare
in 1972, Trypanosoma brucei gambiense, Trypanosoma brucei rho-
desiense, and Trypanosoma brucei brucei were distinguished, and
classified, by geographical location, clinical presentation, and host
range (4). T. b. brucei infects wildlife and livestock but not hu-
mans.T. b. rhodesiense occurs in southern and southeastern Africa
and is associated with acute disease in humans. Its capacity to
infect humans is conferred by a single gene: the serum resistance
antigen (SRA) gene. T. b. gambiense is found in West and Central
Africa and is observed to cause a chronic disease in humans which
often takes months or years to develop into a severe illness.
T. b. gambiense has since been split into two genetically distinct
groups; type 1 T. b. gambiense is clonal (5) and less virulent in
experimental rodents than type 2 T. b. gambiense (6), while type 2
T. b. gambiense is more similar to T. b. brucei (7) and is more
infective in experimental rodents than type 1 T. b. gambiense (8).
There is evidence from microsatellite genotypes and kinetoplast
(mitochondrial) DNA sequences of 142 samples species-wide that
T. b. rhodesiense is a host range variant of T. b. brucei (8, 9).
The distinguishing clinical differences between the two
human-infective subspecies are becoming less clear-cut; descrip-
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tions of both acute (10) and asymptomatic (11) T. b. gambiense
infections exist from Côte d’Ivoire. In T. b. rhodesiense there have
been asymptomatic carriers in Botswana (12), mild disease in
Zambia and Malawi (13, 14), and reports of severe, acute disease
in Uganda (15). In the last case, the isolates collected from a 1989
outbreak in southeastern Uganda displayed a correlation between
disease profile and themultilocus enzyme electrophoresis (MLEE)
strain group, suggesting that genetic variation may underlie the
differences in observed virulence. Themost prevalent zymodemes
from within these strain groups were Busoga 17 (B17) and Zam-
bezi 310 (Z310). Z310 isolateswere associatedwith amore chronic
infection than B17 isolates, and patients were often unaware of
being infected due to a lack of a chancre at the site of a tsetse bite.
Patients infected with Z310 parasites often presented at clinics
with the more serious late-stage disease. B17 patients often pre-
sented earlier in the course of infection, especially as chancres
were often present and patients had learned to associate these with
T. b. rhodesiense infections. Those patients that had been observed
with late-stage B17 infections had progressed to this stage rapidly,
with severe symptoms.
We have used high-throughput sequencing to identify
genome-wide single nucleotide polymorphisms (SNPs) in the ge-
nomes of one Zambezi (Z310) strain and one Busoga (B17) strain
in order to better understandwhich genetic locimay contribute to
the observed differences in virulence fromwithin a single localized
outbreak.We have used SNPs discovered by sequencing to further
genotype 31 isolates from Uganda, together with additional con-
trols. We present the first genomic sequence data for the East
African form of the disease, which can now be compared to the
available T. b. brucei and T. b. gambiense sequences. Furthermore,
we have compared the genome sequences of the three subspecies,
which revealed evidence of genetic exchange between the East and
West African populations. We replicated the human clinical phe-
notype inmousemodels. Our data suggest that certain patterns of
introgressionmay be linkedwith increased-virulence phenotypes.
RESULTS
Microsatellite analysis cannot separate the Zambezi and Busoga
zymodeme strain groups. Samples originating from theUgandan
outbreak of HAT from 1989 to 1993, for which clinical presenta-
tions have previously been described (15) (see Table S1 in the
supplemental material), were taken. Thirty-one strains belonging
to nine known zymodemes of T. b. rhodesiense were examined at
11 informativemicrosatellite loci (Table S2). Clustering the geno-
type data using a neighbor-joining (NJ) method based on Jacca-
rd’s similarity index revealed few branches with strong bootstrap
support. There were three major distinct groups of individuals,
including a single group containing Z366 isolates as well as a B376
isolate, a Z377 isolate, and an additional isolate of unknown zy-
modeme, which clustered separately (Fig. 1).
Whole-genome sequencing reveals regions of heterozygosity
that correspond with shared alleles betweenT.b. gambiense and
T. b. rhodesiense. After sequencing by oligonucleotide ligation
and detection (SOLiD), we aligned reads for B17 andZ310 isolates
with that of the T. b. brucei TREU927 reference strain (Table 1).
Comparing SNPs of the sequenced T. b. rhodesiense isolates to
both T. b. brucei TREU927 and type 1 T. b. gambiense (DAL972)
showed regions within chromosomes 2, 3, 5, 8, and 10 in which
heterozygosity in one of the sequenced T. b. rhodesiense isolates
was associated with alleles shared with the T. b. gambiense refer-
ence (Fig. 2). The sizes of these regions vary; however, the most
striking findings are that ~73% of chromosome 8 of B17 is
heterozygous for alleles of T. b. brucei TREU927 and T. b. gam-
biense DAL972 and that Z310 is homozygous and similar to
T. b. bruceiTREU927 in the same region, as indicated by a block of
blue, representing only one shared allele with the respective refer-
ence sequence. Sequence comparison of B17 and Z310 shows that
FIG 1 Dendrogram showing the relationship between 31 T. b. rhodesiense
isolates at 11 informative microsatellite loci. Isolate numbers (Table S1) are
shown alongside their respective zymodemes (where known). The tree was
generated using an NJ method using Jaccard’s similarity index. Bootstrap val-
ues are based on 100 replicates, and those 50 are indicated on the dendro-
gram. Isolates are color coded according to zymodeme, as follows: Zambezi
366, green; Zambezi 309, 310, and 311, red; Busoga 17 and 376, blue; and
Zambezi 375 and 377, black.
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the genomes are 99.8% identical overall; however, at SNP loci,
the B17 isolate is 23%more similar to type 1 T. b. gambiense than
the Z310 isolate is.
A Jukes-Cantor neighbor-joining (NJ) tree of the 118,161
genome-wide SNP loci shows that West African T. b. gambiense
and T. b. brucei cluster separately from East African T. b. brucei
and T. b. rhodesiense (Fig. 3A). However, different phylogenetic
relationships can be seen upon splitting these data into individual
chromosomes. Figure 3B shows a similar Jukes-Cantor NJ tree in
whichZ310 chromosome 8 ismore closely related to chromosome
8 in T. b. brucei strains than in other strains, whereas T. b. rhod-
esiense B17 chromosome 8 is located between chromosomes 8 of
East African T. b. brucei TREU927/STIB247 and West African
T. b. gambiense/T. b. brucei, as expected, since chromosome 8 is
heterozygous for a haplotype that shares one allele with each of
T. b. brucei and T. b. gambiense.
In order to investigate the position of the T. b. rhodesiense
strains in the context of a wider number of isolates, 50 SNP assays
were designed and genotyped using KASPar competitive allele-
specific-PCR-based genotyping (details can be found at http:
//www.kbioscience.co.uk). SNPs were genotyped from 31
T. b. rhodesiense samples (15) and a single sample from a 2010
patient from Zambia (sample 32) (16). A further 31 isolates from
Western Africa (17) representing 5 type 1 and 12 type 2 T. b. gam-
biense isolates, 11 T. b. brucei isolates, and 3 isolates of unknown
T. brucei subspecies were genotyped in a similar manner (Ta-
ble S3).
Examining KASPar SNP data on a SplitsTree phylogenetic net-
work revealed patterns consistent with recombination, repre-
sented by a net at the center of the tree (Fig. 3C). Interestingly,
WestAfrican isolates ofT. b. brucei and type 1 and type 2T. b. gam-
biense clustered together, suggesting thatWest African T. b. brucei
strains aremore closely related toT. b. gambiense thanEast African
parasites of the same subspecies. B17 and Z310 populations are
situated together near the other sequenced T. b. rhodesiense iso-
lates and distinct from East African T. b. brucei and West African
parasites, including T. b. gambiense and T. b. brucei. Z366 isolates
were tightly clustered, distinct from other T. b. rhodesiense zy-
modemes, and situated between T. b. brucei and T. b. gambiense.
The chromosome 8 SNPs again show that the B17 strains resemble
theT. b. gambiense genotypemore closely than the Z310 strains do
(Fig. 3D). Figure 3D also shows the B17 zymodeme as equidistant
between the East African and West African parasites, which is
consistent with it being heterozygous for the two genotypes.
Human virulence phenotypes can be replicated in experi-
mental mouse infections. Different clinical phenotypes were ob-
served in humans infected with the two predominant zymodemes
from the Ugandan focus of T. b. rhodesiense (15), and we quanti-
tatively reproduced the different virulence phenotypes in mice.
Experimental infections were carried out for three isolates of each
zymodeme in outbredCD-1mice. Parasitemia levels and the over-
all condition and behavior of the mouse were monitored. Mice
infected with B17 isolates survived for longer periods than mice
infected with a Z310 isolate despite a higher first peak of para-
sitemia at 3 to 5 days postinfection (Fig. 4A). B17 isolate-infected
mice did not appear ill and never needed to be killed prior to the
endpoint of the experiment (38 days postinfection). Z310
parasite-infected CD-1 mice showed a generally higher, more
variable level of parasitemia (with a lower initial peak) and showed
more-severe symptoms associated with infection; 72% of these
mice were humanely killed before the end of the experiment due
to deterioration in health. Z310 isolate-infectedmice had a signif-
icantly higher parasitemia at the time of death than B17 isolate-
infected mice (Mann-Whitney, P  0.001). Mice infected with
Z310 parasites lived for a significantly shorter length of time than
mice infected with B17 trypanosomes (P 0.01).
DISCUSSION
Possible origins of the B17 and Z310 genotypes. Uganda is
unique in that populations of all three subspecies of T. brucei are
present in the country. The known ranges of T. b. gambiense and
T. b. rhodesiense strains do not overlap (18); however, it is still
possible that recombination occurs between subspecies where the
ranges of the animal reservoirs of the parasite overlap (e.g., in the
underlying T. b. brucei population). It has been reported recently
that microsatellite markers are consistent with recombination be-
tweenT. b. brucei andT. b. rhodesiense (19), yet there have been no
reports of recombination in the field between T. b. gambiense and
either of the other subspecies. Our SNPmarkers suggest thatWest
African T. b. brucei is more similar to T. b. gambiense than to East
African T. b. brucei. The B17 and Z310 isolates therefore appear to
be the products of recombination between East andWest African
parasites that have expanded clonally in this particular epidemic.
Whether this recombinationwas directly betweenT. b. rhodesiense
and T. b. gambiense or between T. b. rhodesiense andWest African
T. b. brucei cannot be determined from our data. Alternatively, it
may be that recombination, followed by losses of heterozygosity at
multiple loci, has occurred to generate the different clonal groups.
Other protozoan parasites undergo recombination to produce
new, differentially virulent outbreaks; recombination between
two ancestral lineages of Toxoplasma gondii has resulted in a pan-
demic outbreak and the currently circulating clonal genotypes.
Furthermore, some progeny from laboratory crosses between
these lineages were more virulent than the parental lines (20). It
remains to be seen whether other species of African trypanosomes
also undergo similar processes, although differential virulence is
observedwithin and between different genetic groups ofTrypano-
soma congolense (21). Certainly, the ability for genetic exchange to
TABLE 1 SOLiD sequencing metricsa
Zymodeme
Total no. of
sequencing
reads (thousands)
Mean
coverage
at SNP loci
No. of SNPs vs
T. b. brucei TREU927/4
No. of SNPs vs alternative T. b. rhodesiense
isolate
Total 10 coverage Total Homozygous Heterozygous
Z310 58.49 53 132,389 116,065 18,607 4,062 14,545
B17 61.26 52 137,665 121,202 24,987 6,495 18,492
a Summary statistics for SOLiD sequencing of two T. b. rhodesiense strains. Sequencing reads were aligned to the genome and aligned to the ~26-Mbp T. b. brucei TREU927/4
reference sequence. Mean coverage at SNP loci was determined by the SAMtools (32) Pileup package.
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spread phenotypes, such as virulence or drug resistance, through-
out a population means that the situation must be monitored,
particularly in the case of T. congolense and T. vivax, due to the
impact of the diseases on human welfare (3).
The reassortment of alleles between different subspecies may
have an impact not only on virulence but also on other pheno-
types, such as host range and, arguably more importantly, drug
resistance; there are increasing reports of treatment failures in the
major frontline drugs used in the treatment of sleeping sickness,
and resistance is relatively simple to produce in the laboratory
(22). Given that, in Uganda, the two forms of HAT exist only
100 km apart (18), these data suggest that close monitoring of the
circulating genotypes is necessary if the current trend of decreas-
ing infections across Africa is to continue (1).
Alleles on chromosome 8 that are shared with West African
T. bruceimay underlie differences in virulence between the B17
and Z310 zymodemes. Analysis of the genome-wide SNP loci
shows that the sampled B17 and Z310 genomes are extremely
similar; themean percentage difference between strains is0.2%.
A heatmap of percentage similarity between the sequenced
T. b. rhodesiense isolates and East African T. b. brucei TREU927
(Fig. 2A to C) suggests that variation between the B17 and Z310
zymodemes is largely restricted to differences at heterozygous loci
on chromosomes 3, 5, 8, and 10. The largest such locus was on
chromosome 8, and the B17 isolate is heterozygous across70%
of this 2.5-Mbp chromosome.
The KASPar SNP genotyping and data from public sequence
databases for 31 loci across a total of 63 T. brucei subsp. isolates
from Uganda, Zambia, and Côte d’Ivoire suggest that all isolates
within the B17 population have alleles similar to those of the se-
quenced isolate (see Table S4 in the supplementalmaterial). How-
ever, when the entire population of B17 isolates is sampled, there
are only a few sites that have a unique allele that is not shared with
Z310 isolates. These alleles are clustered on chromosome 8.While
there is apparent linkage disequilibrium between these alleles and
other parts of the genome, chromosome 8 is a strong candidate for
loci that could underlie differences in virulence between B17 and
Z310 parasites.
Examining chromosome 8 SNPs on a neighbor-joining tree
(Fig. 3B) suggests that B17, EATRO3, and EATRO2340 parasites
are heterozygous on chromosome 8, with shared alleles from both
type 1 T. b. gambiense and T. b. brucei TREU927 (Fig. 3D). The
Z310 zymodeme, by contrast, has few shared alleles with
T. b. gambienseDAL972 on chromosome 8 and is more similar to
the East African T. b. brucei TREU927.
Only the isocitrate dehydrogenase (ICD) isoenzyme consis-
tently differentiates between the Zambezi and Busoga strain
groups. The ICD gene on chromosome 8 is in the region that is
heterozygous for T. b. brucei TREU927 and type 1 T. b. gambiense
FIG 2 Plot of nonsynonymous SNPs (nsSNPs) in T. b. rhodesiense Z310 and
T. b. rhodesiense B17 strains. Alleles are shown with respect to their matching
allele in either T. b. brucei TREU927/4 (Tbb) or T. b. gambienseDAL972 (type
1) (Tbg). In total, 2,787 nsSNPs are displayed (SNPs in VSG-encoding ele-
ments have been excluded). Colors are as follows: green, two shared alleles (i.e.,
the strains are homozygous); blue, one shared allele (i.e., heterozygous); and
red, no shared alleles. Chromosomes are represented along the y axis. In this
manner, Z310 chromosome 8 can be seen to be homozygously similar to
T. b. brucei and not T. b. gambiense, whereas B17 shares one allele each with
T. b. brucei and T. b. gambiense.
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alleles in B17 isolates. The ICD gene contains 3 nonsynonymous
SNPs (nsSNPs) that are predicted to modify the charge and iso-
electric point of the predicted protein and consequently the mo-
bility of the ICD isoenzyme. ICD mobility determines placement
in the Zambezi and Busoga strain groups, which correlates with
virulence (15). Therefore, the isoenzyme data are consistent with
the SNP genotype data, both of which implicate the heterozygous
region of chromosome 8 as a major locus contributing to the
observed differences in virulence.
Conclusions. Our analysis demonstrates that the T. b. brucei
subspecies causing HAT have undergone genetic exchange in nat-
ural populations, since the East African B17 and Z310 parasites
share alleles with West African type 1 T. b. gambiense. The associ-
ated differences in disease progression in isolates with differen-
tially derived haplotypes has clear implications for parasite con-
trol and diagnosis, as other important traits, such as human serum
resistance or drug resistance, may move between parasite groups.
It will be important to identify how common this process is and
where recombination occurs in the field.
Full-genome sequencing has been able to identify subtle ge-
netic differences between parasite groups that were not apparent
from microsatellite typing; however, other polymorphisms, such
as small insertions and deletions, could not be detected by the
sequencing chemistry. Nevertheless, the SNP data presented in
FIG 3 SplitsTree networks and trees. (A and B) Bootstrapped, EqualAngle Jukes-Cantor NJ tree of next-generation whole-genome sequencing data. Bootstraps
are based on 1,000 replicates. (A) Genome-wide SNP loci (n 118,161), excluding VSG coding sequences; (B) as in panel A but limited to 9,443 SNP loci on
chromosome 8; (C and D) EqualAngle networks for 63 T. brucei isolates generated from KASPar genotyping and publicly available next-generation sequencing
data; (C) 31 genome-wide SNP loci; (D) 7 SNP loci for chromosome 8 only. Strains included T. b. brucei TREU927, STIB247, the TREU927  STIB247
cross, T. b. gambiense type 1 (DAL972) and type 2 (STIB386), and the T. b. brucei  T. b. gambiense cross (STIB247  STIB386). T. b. rhodesiense strains are
indicated by their respective zymodemes, except for EATRO3 and EATRO2340 (see the text in the supplemental material). Colors represent groups of similar
subspecies in each zymodeme, as follows: blue, T. b. rhodesiense B17; red, T. b. rhodesiense Z310; green, T. b. rhodesiense Z366; gray, East African T. b. brucei; and
yellow, Central/West African T. b. gambiense/T. b. brucei.
Genomic Introgression in Trypanosoma brucei
July/August 2013 Volume 4 Issue 4 e00197-13 ® mbio.asm.org 5
this study have been used to generate a panel of KASPar SNP
markers that can now be employed to identify shared alleles and
candidate loci underlying phenotypic differences. These tech-
niques could be useful tools for further screening of field isolates
in future studies.
MATERIALS AND METHODS
Trypanosome stocks. All parasite samples were from preexisting collec-
tions at the Liverpool School of Tropical Medicine and the University of
Glasgow and have been described previously (15–17). All parasites were
isolated from blood samples collected for diagnostic purposes and collec-
tion, and usewas not subject to internal review board consent. All samples
were anonymized for this study.
All animal workwas performed in strict accordancewithUnitedKing-
dom Home Office regulations under project license number PPL40/3162
(loci controlling the response to Trypanosoma brucei).
Thirty-one of the 32 T. b. rhodesiense isolates used in this study have
been previously described (15) (see Table S1 in the supplemental mate-
rial). Sample 32 was isolated from a patient visiting Zambia in 2010 who
presented with a rapidly developing, severe T. b. rhodesiense infection
(16). Samples 33 to 63 are T. b. brucei and T. b. gambiense isolates from
West Africa from an earlier study (17) Table S3). All of the study isolates
had previously been passaged through mice fewer than three times. Zy-
modeme profiles discussed are according to thework of Stevens et al. (23).
Multilocus microsatellite genotyping. Multilocus genotyping at 12
microsatellite loci was used to compare the genotypes of 31 T. b. rhod-
esiense isolates. Isolates stored as blood stabilates were recovered from
liquid nitrogen, and 0.2ml was injected intraperitoneally into CD-1mice.
From 3 days postinfection, parasitemia was assessed daily, and those mice
found to have a high level of parasitemia were immediately killed and
exsanguinated by cardiac puncture; the blood was placed in 4 mM EDTA
(used as an anticoagulant). DNAwas extracted frommouse blood using a
DNeasy blood and tissue kit (Qiagen) per the manufacturer’s instruc-
tions. In order to increase the amount of DNA available for PCR and
subsequent storage, isolates that had previously been stored as stabilate
procyclic cultures were additionally amplified in triplicate using 29-
based whole-genome amplification (Illustra GenomiPhi v2 DNA ampli-
fication kit; GEHealthcare), and duplicate reactionmixtures were pooled
prior to subsequent use.
Microsatellite repeats on chromosome 8 were identified on the
T. b. brucei TREU927 version 4 (TREU927/4) genome sequence (24, 25)
using a local Perl script as previously described (26). PCR primers sur-
rounding these sequences were designed with PRIMER3 (27). Full details
of all primers used in this study, 10 of which have been described else-
where (9, 14), are available in Table S2 in the supplemental material.
PCRs were performed using PCR buffer [45 mM Tris-HCl, pH 8.8,
11 mM (NH4)2SO4, 4.5 mMMgCl2, 6.7 mM 2-mercaptoethanol, 4.4M
EDTA, 113 g/ml bovine serum albumin (BSA), 1 mM concentration of
each of the four deoxyribonucleotide triphosphates], 1Meach oligonu-
cleotide primer, and 0.5 U of Taq polymerase (custom made by Thermo
Scientific) was used per 10-l reaction mixture. Alternatively, ReddyMix
(Thermo Scientific) was used for some PCRs. In both cases, 1 l of tem-
plate DNA (20 ng/liter) was used, except in the case of nested PCR,
where 1 l of a 1/100 dilution of the first product was used in the subse-
quent nested reaction. The cycling conditions in every case were as fol-
lows: 30 cycles of 95°C for 10 s, with a melting temperature (Tm) of5°C
for 30 s, and 72°C for 10 s. PCR products were visualized by electropho-
resis of ethidium bromide-stained agarose gel (NuSieve GTG; Cambrex,
NJ) and visualized under UV light.
Genotyping primers included a 5=-end fluorescent dye modification
(6-carboxyfluorescein [FAM]), which enabled accurate detection and siz-
ing using a capillary-based sequencing instrument (ABI 3130/ABI 3100;
Applied Biosystems, Foster City, CA, USA) against a set of 6-caboxyl-X-
rhodamine (ROX)-labeled proprietary size standards (GS-LIZ500; Ap-
plied Biosystems). Allele scores were generated using Peak Scanner soft-
ware (Applied Biosystems).
A bootstrapped dendrogram showing the relationship between the
different T. b. rhodesiense multilocus genotypes was generated by the
neighbor-joining method using Jaccard’s similarity index. One marker
that was found to be uninformative across all samples (M12C12) was
removed prior to subsequent analysis. Bootstrap values were based on 100
replicates, and those70 are indicated on the dendrogram (28).
SOLiD sequencing of B17 and Z310 isolates.Two isolates ofT. b. rho-
desiense, one each of zymodemes B17 (isolate 2) (Table S1) and Z310
(isolate 5), were cultured as described previously (29); briefly, parasites
weremaintained in SDM-79 supplementedwith sterile fetal bovine serum
to a concentration of 10% (vol/vol) and streptomycin (10mg/ml) at 27°C
in increasing volumes (2 to 5 ml), until sufficient parasite counts were
obtained for DNA extraction and sequencing (~50 ng genomic DNA).
DNA from cultured parasites was extracted using a blood and cell culture
DNA kit (Qiagen, United Kingdom). Sequencing libraries were prepared
and amplified by emulsion PCR according to the manufacturer’s proto-
cols (Life Technologies, USA).Whole-genome sequencingwas performed
on a single slide using the ABI SOLiD analyzer, version 3 (Life Technolo-
gies, Foster City, CA). The resulting colorspace sequences weremapped to
the T. b. brucei TREU927/4 genome sequence (24, 25) using Bowtie (30).
Sequencing reads and associated coverage were visualized using the IGV
browser (31). SNPs were extracted using the SAMtools pipeline (32) and
entered into a MySQL database using a Perl script; SNPs associated with
low coverage (5) were removed. The resulting filtered SNPs were
compared to generate lists of SNPs shared by each isolate and for unique
homozygous and heterozygous SNPs for each zymodeme. Nonsynony-
mous SNPs were identified using a bespoke Perl script.
Publicly available sequence data. Publicly available genome se-
quences for T. brucei subsp. isolates were downloaded from the Sequence
Read Archive (http://trace.ncbi.nlm.nih.gov) for T. b. brucei
(TREU927/4; accession number ERX009953) and for the progeny of a
laboratory cross between T. b. brucei STIB247 and TREU927 (accession
number ERX008996), a 1960 UgandanT. b. rhodesiense isolate (EATRO3;
accession number ERX007603), a 1977 Kenyan T. b. rhodesiense isolate
(EATRO2340; accession number ERX007601), and the progeny of a lab-
oratory cross between type 2 T. b. gambiense STIB386 and T. b. brucei
FIG 4 Parasitemia in T. b. rhodesiense-infected mice. Line graph of mean
parasitemia in CD-1 mice infected with B17 and Z310 zymodeme T. b. rhod-
esiense parasites  standard errors (25 fields, thick film, 400 objective).
Three isolates of each of the two zymodemes were each used to infect 12 mice
(total of 72 mice). We killed 12 mice per week (two per parasite isolate), plus
any mice that were killed due to moderate symptoms.
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STIB247 (accession number ERX000726). Similarly, sequencing reads for
T. b. brucei (STIB247), a type 1T. b. gambiense isolate (DAL972) (33), and
a type 2 T. b. gambiense isolate from the Ivory Coast (STIB386) were
downloaded directly from the Wellcome Trust Sanger Institute (WTSI)
FTP website (ftp://ftp.sanger.ac.uk/pub/pathogens/Trypanosoma/brucei
/T.b.gambiense_sequences/). All publicly available sequence data were
generated using an Illumina genetic analyzer, except data for DAL972,
which was sequenced using dideoxynucleotide (Sanger) sequencing (33).
Sanger sequence read lengths exceed the maximum read length permissi-
ble by the Bowtie aligner. Therefore, Sanger reads were artificially split
into 50-bp reads using a Perl script and treated as per next-generation
sequencing data in order to align all data using the same alignment soft-
ware. The Illumina genetic analyzer and artificial 50-bp Sanger sequenc-
ing reads were aligned to the T. b. brucei TREU927/4 reference sequence
using Bowtie (30). SNPs between the downloaded genomes were ex-
tracted using the Pileup feature in the SAMtools package (32). SNP loci
were identified where an SNP was present in at least one genome and
where there was5-fold coverage in all genomes studied. For the SOLiD-
sequenced genomes of T. b. rhodesiense B17 and Z310 isolates, the mean
coverage at SNP loci was ~52-fold (Table 1). Due to the high copy number
and variability in genes coding for variable surface glycoproteins (VSG),
any SNP located within the boundaries of a VSG coding sequence were
removed. A total of 109,495 non-VSG SNP loci were identified.
Selection of SNP loci for KASPar genotyping. In order to genotype a
wider range of T. brucei subsp. isolates from both Uganda (T. b. rhod-
esiense) and West Africa (T. b. brucei/T. b. gambiense), duplicate whole-
genome amplification (WGA) reactions (IllustraGenomiPhi v2DNAam-
plification kit; GE Healthcare) were performed on DNA extracted from
stabilates (Ugandan samples) or fromWhatman FTA punches (West Af-
rican samples). DNA was extracted and WGA reactions were performed
according to the manufacturer’s instructions as previously described.
Fifty nonsynonymous SNP loci (25 homozygous and 25 heterozy-
gous) were selected from the MySQL database of all SNPs between B17
and Z310 isolates for subsequent typing of the remaining isolates. Loci
were evenly distributed across all 11 megabase chromosomes, and all had
a low (0) BLOSUM50 score, indicating that they might modify protein
activity. A 100-bp window surrounding the SNPs was extracted from a
consensus sequence for the B17 and Z310 genomes using a Perl script and
submitted to KBiosciences Ltd. (Hoddesdon, United Kingdom) along
with DNA from a total of 63 isolates for SNP genotyping using their
proprietary KASPar platform (http://www.kbioscience.co.uk/). Of the 50
SNP loci selected, 31 loci were successfully genotyped (Table S5). These
assays are available to other users on application to KBiosciences.
Genome-wide SNP analyses. Two thousand seven hundred eighty-
seven genome-wide, nonsynonymous SNPs between the T. b. rhodesiense
B17 and Z310 genomes were compared to T. b. brucei (TREU927/4) and
T. b. gambiense (type 1, DAL972). A plot showing homozygosity and
heterozygosity at these loci is shown in Fig. 2. Additionally, a bootstrapped
(based on 1,000 replicates) Jukes-Cantor neighbor-joining (NJ) tree was
created using SplitsTree for genome-wide SNP loci (Fig. 3A) and for those
situated on chromosome 8 (Fig. 3B) (28).
Nucleotide sequence accession number. Sequence data have been
submitted to the European Nucleotide Archive under study accession
number ERP001836.
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/lookup/suppl/doi:10.1128/mBio.00197-13/-/DCSupplemental.
Table S1, DOCX file, 0.1 MB.
Table S2, DOCX file, 0.1 MB.
Table S3, DOCX file, 0 MB.
Table S4, XLSX file, 0.1 MB.
Table S5, PDF file, 0.1 MB.
ACKNOWLEDGMENTS
I.G. was supported by a University of Liverpool Ph.D. studentship. Much
of the work was funded by a Royal Society Wolfson Merit Award to
N.H. S.K. was supported by an MRC award to N.H. A.M. was supported
by a Wellcome Trust career development fellowship (reference number
079703/Z/06/Z) and aWellcome Trust senior fellowship (reference num-
ber 095201/Z/10/Z).
REFERENCES
1. Simarro PP, Diarra A, Ruiz Postigo JA, Franco JR, Jannin JG. 2011. The
human African trypanosomiasis control and surveillance programme of
the World Health Organization 2000–2009: the way forward. PLoS Negl.
Trop. Dis. 5(2):e1007. doi:10.1371/journal.pntd.0001007.
2. World Health Organization. 2013. Trypanosomiasis, human African
(sleeping sickness), factsheet 259. World Health Organization, Geneva,
Switzerland. http://www.who.int/mediacentre/factsheets/fs259/en/.
3. Kristjanson P, Swallow BM, Rowlands G, Kruska R, De Leeuw P. 1999.
Measuring the costs of African animal trypanosomosis, the potential ben-
efits of control and returns to research. Agric. Sys. 59:79–98.
4. Hoare C. 1972, The trypanosomes of mammals. Blackwell Scientific Pub-
lications, Oxford, United Kingdom.
5. Morrison LJ, Tait A, McCormack G, Sweeney L, Black A, Truc P,
Likeufack AC, Turner CM, MacLeod A. 2008. Trypanosoma brucei gam-
biense type 1 populations from human patients are clonal and display
geographical genetic differentiation. Infect. Genet. Evol. 8:847–854.
6. Gibson WC. 1986. Will the real Trypanosoma b. gambiense please stand
up. Parasitol. Today 2:255–257.
7. MacLeod A, Turner CM, Tait A. 2001. The detection of geographical
substructuring ofTrypanosoma brucei populations by the analysis ofmini-
satellite polymorphisms. Parasitology 123:475–482.
8. Gibson W. 2007. Resolution of the species problem in African trypano-
somes. Int. J. Parasitol. 37:829–838.
9. Balmer O, Palma C, Macleod A, Caccone A. 2006. Characterization of
di-, tri-, and tetranucleotide microsatellite markers with perfect repeats
for Trypanosoma brucei and related species. Mol. Ecol. Notes 6:508–510.
10. Truc P, Formenty P, Diallo PB, Komoin-Oka C, Lauginie F. 1997.
Confirmation of two distinct classes of zymodemes ofTrypanosoma brucei
infectingman andwildmammals in Côte d’Ivoire: suspected difference in
pathogenicity. Ann. Trop. Med. Parasitol. 91:951–956.
11. Jamonneau V, Ravel S, Garcia A, Koffi M, Truc P, Laveissière C, Herder
S, Grébaut P, Cuny G, Solano P. 2004. Characterization of Trypanosoma
brucei s.l. infecting asymptomatic sleeping-sickness patients in Côte
d’Ivoire: a new genetic group? Ann. Trop. Med. Parasitol. 98:329–337.
12. Apted FI, Smyly DP, Ormerod WE, Stronach BW. 1963. A comparative
study of the epidemiology of endemic Rhodesian sleeping sickness in dif-
ferent parts of Africa. J. Trop. Med. Hyg. 66:1–16.
13. Hide G, Buchanan N, Welburn S, Maudlin I, Barry JD, Tait A. 1991.
Trypanosoma brucei rhodesiense: characterisation of stocks from Zambia,
Kenya, and Uganda using repetitive DNA probes. Exp. Parasitol. 72:
430–439.
14. Maclean L, Odiit M, Macleod A, Morrison L, Sweeney L, Cooper A,
Kennedy PG, Sternberg JM. 2007. Spatially and genetically distinct Afri-
can Trypanosome virulence variants defined by host interferon-gamma
response. Infect. Dis. 196:1620–1628.
15. Smith DH, Bailey JW. 1997. Human African trypanosomiasis in south-
eastern Uganda: clinical diversity and isoenzyme profiles. Ann. Trop.
Med. Parasitol. 91:851–856.
16. Cottle LE, Peters JR, Hall A, Bailey JW, Noyes HA, Rimington JE,
Beeching NJ, Squire SB, Beadsworth MB. 2012. Multiorgan dysfunction
caused by travel-associated African trypanosomiasis. Emerg. Infect. Dis.
18:287–289.
17. Mehlitz D, Zillmann U, Scott CM, Godfrey DG. 1982. Epidemiological
studies on the animal reservoir of Gambiense sleeping sickness. Part III.
Characterization of trypanozoon stocks by isoenzymes and sensitivity to
human serum. Tropenmed. Parasitol. 33:113–118.
18. Picozzi K, Fèvre EM, Odiit M, Carrington M, Eisler MC, Maudlin I,
Welburn SC. 2005. Sleeping sickness in Uganda: a thin line between two
fatal diseases. BMJ 331:1238–1241.
19. Balmer O, Beadell JS, Gibson W, Caccone A. 2011. Phylogeography and
taxonomy of Trypanosoma brucei. PLoS Negl. Trop. Dis. 5(2):e961. doi:
10.1371/journal.pntd.0000961.
Genomic Introgression in Trypanosoma brucei
July/August 2013 Volume 4 Issue 4 e00197-13 ® mbio.asm.org 7
20. Grigg ME, Bonnefoy S, Hehl AB, Suzuki Y, Boothroyd JC. 2001. Success
and virulence in Toxoplasma as the result of sexual recombination be-
tween two distinct ancestries. Science 294:161–165.
21. Masumu J, Marcotty T, Geysen D, Geerts S, Vercruysse J, Dorny P, den
Bossche PV. 2006. Comparison of the virulence of Trypanosoma congo-
lense strains isolated from cattle in a trypanosomiasis endemic area of
eastern Zambia. Int. J. Parasitol. 36:497–501.
22. Vincent IM, Creek D, Watson DG, Kamleh MA, Woods DJ, Wong PE,
Burchmore RJ, Barrett MP. 2010. A molecular mechanism for eflorni-
thine resistance in African trypanosomes. PLoS Pathog. 6(11):e1001204.
doi:10.1371/journal.ppat.1001204.
23. Stevens JR, Lanham SM, Allingham R, Gashumba JK. 1992. A simplified
method for identifying subspecies and strain groups in Trypanozoon by
isoenzymes. Ann. Trop. Med. Parasitol. 86:9–28.
24. Berriman M, Ghedin E, Hertz-Fowler C, Blandin G, Renauld H, Bar-
tholomeu DC, Lennard NJ, Caler E, Hamlin NE, Haas B, Böhme U,
Hannick L, Aslett MA, Shallom J, Marcello L, Hou L, Wickstead B,
Alsmark UC, Arrowsmith C, Atkin RJ, Barron AJ, Bringaud F, Brooks
K, Carrington M, Cherevach I, Chillingworth TJ, Churcher C, Clark
LN, Corton CH, Cronin A, Davies RM, Doggett J, Djikeng A, Feld-
blyum T, Field MC, Fraser A, Goodhead I, Hance Z, Harper D, Harris
BR, Hauser H, Hostetler J, Ivens A, Jagels K, Johnson D, Johnson J,
Jones K, Kerhornou AX, Koo H, Larke N, Landfear S, Larkin C, Leech
V, Line A, Lord A, Macleod A, Mooney PJ, Moule S, Martin DM,
Morgan GW, Mungall K, Norbertczak H, Ormond D, Pai G, Peacock
CS, Peterson J, Quail MA, Rabbinowitsch E, Rajandream MA, Reitter
C, Salzberg SL, Sanders M, Schobel S, Sharp S, Simmonds M, Simpson
AJ, Tallon L, Turner CM, Tait A, Tivey AR, Van Aken S, Walker D,
Wanless D, Wang S, White B, White O, Whitehead S, Woodward J,
Wortman J, Adams MD, Embley TM, Gull K, Ullu E, Barry JD,
Fairlamb AH, Opperdoes F, Barrell BG, Donelson JE, Hall N, Fraser
CM, Melville SE, El-Sayed NM. 2005. The genome of the African try-
panosome Trypanosoma brucei. Science 309:416–422.
25. Hertz-Fowler C, Peacock CS, Wood V, Aslett M, Kerhornou A, Mooney
P, Tivey A, Berriman M, Hall N, Rutherford K, Parkhill J, Ivens AC,
Rajandream MA, Barrell B. 2004. GeneDB: a resource for prokaryotic
and eukaryotic organisms. Nucleic Acids Res. 32:D339–D343.
26. Fakhar M, Motazedian MH, Daly D, Lowe CD, Kemp SJ, Noyes HA.
2008. An integrated pipeline for the development of novel panels of
mapped microsatellite markers for Leishmania donovani complex, Leish-
mania braziliensis and Leishmania major. Parasitology 135:567–574.
27. Rozen S, Skaletsky H. 2000. Primer3 on the WWW for general users and
for biologist programmers. Methods Mol. Biol. 132:365–386.
28. Huson DH. 1998. SplitsTree: analyzing and visualizing evolutionary data.
Bioinformatics 14:68–73.
29. Brun R, Schönenberger. 1979. Cultivation and in vitro cloning or procy-
clic culture forms of Trypanosoma brucei in a semi-defined medium Acta
Trop. 36:289–292.
30. Langmead B, Trapnell C, Pop M, Salzberg SL. 2009. Ultrafast and
memory-efficient alignment of short DNA sequences to the human ge-
nome. Genome Biol. 10:R25. doi:10.1186/gb-2009-10-3-r25.
31. Thorvaldsdóttir H, Robinson JT, Mesirov JP. 2013. Integrative Genom-
ics viewer (IGV): high-performance genomics data visualization and ex-
ploration. Brief. Bioinform. 14:178–192.
32. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, Marth G,
Abecasis G, Durbin R, 1000 Genome Project Data Processing Sub-
group. 2009. The Sequence Alignment/Map (SAM) format and SAM-
tools. Bioinformatics 25:2078–2079.
33. Jackson AP, Sanders M, Berry A, McQuillan J, Aslett MA, Quail MA,
Chukualim B, Capewell P, MacLeod A, Melville SE, Gibson W, Barry
JD, Berriman M, Hertz-Fowler C. 2010. The genome sequence of
Trypanosoma brucei gambiense, causative agent of chronic human Afri-
can trypanosomiasis. PLOS Negl. Trop. Dis. 4(4):e658. doi:10.1371/
journal.pntd.0000658.
34. Ormerod WE. 1963. A comparative study of growth and morphology of
strains of Trypanosoma rhodesiense. Exp. Parasitol. 13:374–385.
35. Seed J, Wenck M. 2003. Role of the long slender to short stumpy transi-
tion in the life cycle of the African trypanosomes. Kinetoplastid Biol. Dis.
2:3. doi:10.1186/1475-9292-2-1.
36. Tyler KM, Higgs PG, Matthews KR, Gull K. 2001. Limitation of
Trypanosoma brucei parasitaemia results from density-dependent parasite
differentiation and parasite killing by the host immune response. Proc.
Biol. Sci. 268:2235–2243.
37. Savill NJ, Seed JR. 2004. Mathematical and statistical analysis of the
Trypanosoma brucei slender to stumpy transition. Parasitology 128:
53–67.
Goodhead et al.
8 ® mbio.asm.org July/August 2013 Volume 4 Issue 4 e00197-13
